Copyright
©The Author(s) 2015.
World J Hepatol. Jul 18, 2015; 7(14): 1843-1855
Published online Jul 18, 2015. doi: 10.4254/wjh.v7.i14.1843
Published online Jul 18, 2015. doi: 10.4254/wjh.v7.i14.1843
Cohort | Regimen | Duration (wk) | SVR12 |
Cohort 1: Prior non-responder HCV | SMV/SOF + RBV | 24 | 79% |
patients with METAVIR scores (F0-F2) | SMV/SOF | 24 | 93% |
SMV/SOF + RBV | 12 | 96% | |
SMV/SOF | 12 | 93% | |
Cohort 2: Prior non-responder and | SMV/SOF + RBV | 24 | 93% |
treatment naïve HCV patients with | SMV/SOF | 24 | 100% |
METAVIR scores (F3-F4) | SMV/SOF + RBV | 12 | 93% |
SMV/SOF | 12 | 93% |
- Citation: Khullar V, Firpi RJ. Hepatitis C cirrhosis: New perspectives for diagnosis and treatment. World J Hepatol 2015; 7(14): 1843-1855
- URL: https://www.wjgnet.com/1948-5182/full/v7/i14/1843.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i14.1843